Why the cyberattack on Ascension scared 5 hospital execs

The latest stories trending on MedCity News.

Editor's Pick

Top Story Why the Cyberattack on Ascension Scared 5 Hospital Execs & How They're Responding As majorly disruptive cyberattacks continue to make headlines in the healthcare world, hospitals are prioritizing cybersecurity more than ever before. This piece explores reactions from five different health system executives about the recent attack on Ascension — as well as what they're doing to prevent a similar fate at their own organization and how they want things to change going forward. Sponsored Unlocking Transparency in PBM Pricing Presented by MedCity News & Abarca Health Dan Reedy, senior director of pricing and underwriting for Abarca, spoke recently with MedCity News about what payers should consider as they explore new models and press for greater transparency. Learn More.

Featured News

GSK's Quest to Bring Myeloma Drug Back to the Market Stops for a Data Drop at ASCO GSK's Blenrep has pivotal clinical trial results showing the multiple myeloma therapy reduced the risk of disease progression or death by nearly 50%. The results were presented Sunday during the annual meeting of the America Society of Clinical Oncology. Newborn Screening + Genome Sequencing: The Formula for Faster Rare Disease Diagnosis? Now is the time for the entire industry to understand what newborn screening and newborn sequencing programs are, how they benefit the rare disease community, and how to maximize their benefits.  At ASCO, AstraZeneca Adds Data Supporting Expanded Use of Its Drugs in Lung Cancer AstraZeneca's Tagrisso and Imfinzi helped patients live longer in separate pivotal clinical trials evaluating the drugs in two different types of lung cancer. The results will be presented Sunday during the annual meeting of the American Society of Clinical Oncology. Gameto Secures $33M To Support Clinical Development of Fertility Treatment Gameto's $33 million Series B funding round was led by Two Sigma Ventures and RA Capital. The funding will help with the clinical development of its in vitro maturation product called Fertilo. How Testosterone is Revolutionizing Menopause Care Shedding light on misconceptions about testosterone and women's health

Resources

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Courtney Fortner, CEO of Navvis In this month's episode, Senior Reporter Katie Adams explored some executive moves and layoffs that recently occurred in the healthcare world. She also interviewed Courtney Fortner, who stepped into the CEO role at population health company Navvis this month. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe